Office-Wide Innovative Solutions Opening for Proactive Health Office (PHO)
ID: ARPA-H-SOL-24-106Type: Solicitation
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFNATIONAL INSTITUTES OF HEALTHNIH ADVANCED RESEARCH PROJECTS AGENCY FOR HEALTH (ARPA-H)Bethesda, MD, 208920004, USA

NAICS

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) (541715)

PSC

HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT (AN13)
Timeline
  1. 1
    Posted Mar 14, 2024, 9:07 PM UTC
  2. 2
    Updated Sep 25, 2024, 12:00 AM UTC
  3. 3
    Due Mar 4, 2029, 4:59 AM UTC
Description

The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is soliciting innovative research proposals aimed at enhancing health outcomes via the Proactive Health Office (PHO). The initiative focuses on developing solutions that prioritize disease prevention, early intervention, and scalable wellness-promoting behaviors, moving away from traditional reactive healthcare models. This opportunity is significant for entities capable of delivering transformative health solutions, with proposals evaluated based on scientific merit and relevance, and funding potentially awarded through Other Transactions or Cooperative Agreements. Interested parties must submit a mandatory solution summary by March 3, 2029, and can direct inquiries to the designated contact via the provided submission platforms.

Point(s) of Contact
Files
Title
Posted
Sep 25, 2024, 11:34 PM UTC
The Advanced Research Projects Agency for Health (ARPA-H) is soliciting innovative research proposals through its Proactive Health Office (PHO) under solicitation number ARPA-H-SOL-24-106. The initiative focuses on enhancing health outcomes by developing solutions that prioritize disease prevention and early intervention, departing from traditional reactive healthcare approaches. Key interest areas include scalable disease detection methods, preventive treatments, and systems that promote wellness behaviors at a population level. Eligible proposers encompass universities, non-profits, small and large businesses, with an emphasis on projects that tackle significant health challenges or offer novel technologies. Proposal submissions must begin with a mandatory solution summary to gauge alignment with ARPA-H’s objectives. A thorough review process based on scientific merit and relevance will determine award-winning proposals, which could be funded through Other Transactions or Cooperative Agreements. The solicitation, open until March 2029, encourages innovative, interdisciplinary approaches and welcomes submissions from diverse entities while emphasizing compliance with federal regulations regarding human and animal research. This RFP represents a significant opportunity for entities capable of delivering transformative health solutions aligned with national health goals.
Sep 25, 2024, 11:34 PM UTC
The document serves as an amendment to the ARPA-H-SOL-24-104, providing a template for submitting solution summaries for federally funded projects. It outlines required components, including a cover letter, concept summary, innovation and impact assessment, proposed work details, team organization, and a basis of estimate for funding. Submissions must be concise, adhering to formatting guidelines, and not exceeding six pages. The concept summary should clearly articulate how the proposed solution addresses specific HSF interest areas, emphasizing innovative and potentially disruptive technologies. Detail on outcomes, project deliverables, key milestones, and technical methodologies is essential, along with identification of adoption challenges and mitigation strategies for technical risks. Furthermore, the document emphasizes transparency in the financial component— detailing both the requested funds and project costs, which must encompass labor, materials, travel, and other direct expenses. The roles and qualifications of the project team members are also highlighted, ensuring clarity regarding responsibilities and expertise. This amendment establishes a structured approach for government RFP submissions, focusing on innovation, impact, and practical implementation while promoting compliance with federal funding requirements.
May 2, 2024, 9:40 PM UTC
Mar 28, 2024, 7:16 AM UTC
Sep 25, 2024, 11:34 PM UTC
May 2, 2024, 9:40 PM UTC
The solicitation from the Advanced Research Projects Agency for Health (ARPA-H) is aimed at attracting innovative solutions to enhance health outcomes and prevent diseases through proactive health strategies. It invites proposals from various entities, including universities and non-profits, focusing on novel methods of disease detection, prevention, and wellness behavior promotion, with a submission deadline for solution summaries set for March 3, 2025. Multiple awards including Other Transactions and Cooperative Agreements are anticipated, and proposals will be evaluated based on scientific merit, relevance to health improvement, proposer capabilities, and cost realism.
Mar 28, 2024, 7:16 AM UTC
The Advanced Research Projects Agency for Health (ARPA-H) has released an Innovative Solutions Opening (ISO) solicitation aimed at fostering transformative health research to enhance public health outcomes through proactive measures. Eligible applicants, including universities and small businesses, are invited to submit solution summaries by March 3, 2025, to address specific areas such as disease prevention, early detection methods, and system-level innovations for healthcare delivery. The solicitation seeks novel proposals that offer revolutionary advancements rather than incremental improvements, with plans for multiple awards based on the quality of submissions.
Lifecycle
Title
Type
Solicitation
Similar Opportunities
Office-Wide Innovative Solutions Opening for Health Science Futures (HSF)
Buyer not available
The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is soliciting proposals for the Innovative Solutions Opening (ISO) aimed at advancing healthcare technologies. This initiative seeks innovative, disease-agnostic research projects that can significantly improve health outcomes, focusing on areas such as maternal and fetal health, genetic therapies, and novel diagnostic tools. The solicitation emphasizes the development of transformative solutions rather than incremental research, with submissions required to follow a two-step process: an initial solution summary followed by a full proposal based on feedback received. Interested parties must submit their solution summaries by March 3, 2029, via the designated ARPA-H portal, and are encouraged to review the detailed submission guidelines outlined in the provided documentation.
Office-Wide Innovative Solutions Opening for Scalable Solutions Office (SSO)
Buyer not available
The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is soliciting innovative solutions aimed at enhancing healthcare accessibility, affordability, and scalability. This opportunity invites universities, non-profits, small businesses, and similar entities to submit solution summaries and proposals that address health disparities, improve the distribution of healthcare technologies, and advance biomanufacturing innovations. The solicitation emphasizes the development of scalable technologies and collaborative distribution networks, with a focus on interdisciplinary approaches to revolutionize biomedicine and public health outcomes. Interested parties must submit their solution summaries by March 3, 2029, and can find further details and submission guidelines at https://solutions.arpa-h.gov. For inquiries, questions should be directed to the same website.
PROactive Solutions for Prolonging Resilience (PROSPR)
Buyer not available
The Department of Health and Human Services, through the Advanced Research Projects Agency for Health (ARPA-H), is soliciting proposals for the PROactive Solutions for Prolonging Resilience (PROSPR) program, aimed at developing interventions to extend the healthspan of Americans by addressing age-related health decline. This initiative seeks to negotiate multiple Other Transaction Agreements (OTs) with eligible entities, focusing on three key technical areas: the development of an intrinsic capacity score, repurposing FDA-approved interventions, and creating second-generation interventions. The program is significant for transforming geriatric medicine into a preventive care model, emphasizing health equity and proactive health management for aging populations. Interested proposers can find further details and submit inquiries to the PROSPR Team at PROSPR@arpa-h.gov, with key deadlines for proposal submissions set for April and May 2025.
Office-Wide Innovative Solutions Opening for Resilient Systems Office (RSO)
Buyer not available
The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is soliciting innovative solutions aimed at enhancing the resilience of healthcare systems via its Resilient Systems Office (RSO). This opportunity invites submissions from eligible entities, including universities, nonprofits, and small businesses, to address systemic challenges in healthcare and public health by leveraging cutting-edge technologies that improve care quality and availability. The solicitation emphasizes the importance of sociotechnical system innovations and adaptive solutions that enhance the reliability and interoperability of health ecosystems. Interested parties must submit solution summaries for feedback before full proposal submissions, with the solicitation open until March 3, 2029. For further inquiries, submissions should be directed to the designated online platforms, and the primary contact email is provided in the solicitation details.
Final Innovative Solutions Opening (ISO) ARPA-H Rare Disease AI/ML for Precision Integrated Diagnostics (RAPID)
Buyer not available
The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is soliciting proposals for the Final Innovative Solutions Opening (ISO) under the Rare Disease AI/ML for Precision Integrated Diagnostics (RAPID) program. This initiative aims to significantly enhance the speed and accuracy of diagnosing rare diseases, which affect approximately 30 million Americans, by developing innovative diagnostic support tools and a sustainable data platform optimized for AI-driven solutions. The RAPID program encompasses two phases over 4.5 years, focusing on extensive data curation, multimodal patient data collections, and the establishment of an AI-driven data commons, with the goal of reducing diagnostic delays and improving health management for underserved populations. Proposals are due by April 24, 2025, and interested parties can direct inquiries to the RAPID Email Box at RAPID@ARPA-H.gov.
ADAPT Contract Research Organization Support Services
Buyer not available
The Department of Health and Human Services, through the Advanced Research Projects Agency for Health (ARPA-H), is soliciting proposals for Contract Research Organization (CRO) support services under the ADAPT Contract Research Organization Support Services initiative. This program aims to enhance cancer treatment strategies by developing an adaptive cancer treatment platform that integrates advanced analysis techniques and biomarker discovery to improve patient outcomes for metastatic cancers. The selected contractor will manage clinical trial data, conduct biological assays, and ensure compliance with regulatory standards, with a contract period of one year and four optional renewal years. Proposals are due by April 18, 2025, at 1:00 PM ET, and interested parties should direct inquiries to Steven Snyder at steven.snyder@arpa-h.gov or Clare Sanchez at clare.sanchez@arpa-h.gov.
Ocular Laboratory for Analysis of Biomarkers (OCULAB)
Buyer not available
The Department of Health and Human Services, through the Advanced Research Projects Agency for Health (ARPA-H), is seeking proposals for the Ocular Laboratory for Analysis of Biomarkers (OCULAB) initiative, aimed at advancing the diagnosis and treatment of ocular conditions, particularly dry eye disease (DED). This program invites innovative solutions to develop a continuous monitoring biosensor integrated with therapeutic delivery systems, leveraging AI for non-invasive treatment methods. The initiative emphasizes collaboration among commercial and academic entities to enhance healthcare access and patient outcomes, with multiple awards anticipated based on scientific merit. Interested parties can contact the OCULAB Team at OCULAB@ARPA-H.gov for further information, with key proposal deadlines and requirements outlined in the associated documents.
ARPA-H ImagiNg Data EXchange (INDEX)
Buyer not available
The Department of Health and Human Services, through the Advanced Research Projects Agency for Health (ARPA-H), is soliciting proposals for the Imaging Data Exchange (INDEX) program, aimed at developing a sustainable platform to enhance access to medical imaging data. This initiative seeks to address the growing demand for imaging services and the shortage of qualified radiologists by leveraging artificial intelligence and machine learning to streamline data management and analysis. The program is structured in two phases: Phase 0 focuses on business model development, while Phase 1 involves system design and participant enrollment, with an emphasis on ensuring diverse and representative datasets. Interested parties should submit their proposals by April 21, 2025, and can direct inquiries to the INDEX Team at INDEX@arpa-h.gov.
BARDA DRIVe EZ-BAA (EZBAA - 22-100-SOL-00003)
Buyer not available
The Department of Health and Human Services, through the Biomedical Advanced Research and Development Authority (BARDA), is soliciting innovative research proposals under the Easy Broad Agency Announcement (EZ-BAA) BAA-22-100-SOL-00003. The initiative aims to address high-risk biomedical challenges related to emerging infectious diseases and public health emergencies, with specific Areas of Interest (AOIs) including vaccine efficacy enhancement, portable viral diagnostics, and medical countermeasures for acute radiation syndrome. This opportunity is crucial for advancing public health preparedness and fostering innovation in medical technologies. Interested parties must have active registration with SAM.gov and are encouraged to submit abstracts by various deadlines, with the next significant closing date for AOI submissions set for March 15, 2024. For further inquiries, contact Sieaun Marks at DRIVeAcquisitions@hhs.gov.
A Human Multi-Organ Tissue Equivalent Platform to Model High Consequence Threat Agents
Buyer not available
The Department of Defense, through the Army Medical Research Acquisition Activity, is seeking a contractor to develop a Human Multi-Organ Tissue Equivalent Platform aimed at modeling high consequence threat agents. This initiative focuses on creating a micro-engineered organ/tissue equivalent platform that will facilitate the modeling of pathogenic outcomes from emerging infectious diseases and the testing of medical countermeasures, particularly for respiratory viruses such as SARS-CoV-2, MERS, and pandemic H1N1 influenza. The project is critical for enhancing the military's capability to protect warfighters from both natural and manmade threats, ensuring rapid identification of effective medical responses. Interested contractors must submit their capabilities by 10:00 AM EST on April 14, 2025, and can direct inquiries to Kirstin L. Quinn at Kirstin.L.Quinn.civ@health.mil.